Palantir Shares Fall Over 6% on Morgan Stanley Downgrade
Palantir shares declined more than 6% following Morgan Stanley's Underweight rating, raising concerns about the company's future performance.
Topic
Stock Market
A collection of 1282 issues
Mixed Performance: U.S. Stock Indices Decline
U.S. stock markets experienced declines as S&P 500 fell 0.7%, Nasdaq dropped 1.4%, and Dow Jones dipped 0.1%, signaling mixed investor sentiment.
US Stock Futures Rise Ahead of Tuesday Opening
US stock market sees upward momentum as S&P 500, Dow Jones, and Nasdaq futures gain pre-market. Stay tuned for market updates and analysis.
Nvidia's AI Strategy and Palantir's Stock Rating Shake US Market
Explore how Nvidia's AI advancements and Palantir's stock evaluation are influencing US investors. Discover the latest corporate updates driving market trends.
Uber Shares Unaffected by Nvidia's Self-Driving Partnership
Uber's stock price shows no change despite Nvidia's collaboration on self-driving software, keeping investors watchful. Discover the implications for the ride-hailing giant.
Nvidia Shares Dip 5% Despite Major Partnerships
Nvidia shares fell by 5% despite new partnerships with Aurora, Toyota, and Uber, impacting investor sentiment. Explore the market dynamics and future prospects.
Shutterstock Shares Surge on Getty Images Merger News
Discover how Shutterstock's shares skyrocketed following its merger with Getty Images. Explore the impact on the stock market and future prospects.
Getty Images Shares Surge Following Shutterstock Merger
Getty Images shares see a significant rise as news of its merger with Shutterstock breaks. Discover the financial impact and market reactions.
Palantir Shares Plunge Amid Overvaluation Concerns
Palantir Technologies stock drops as Morgan Stanley warns of overvaluation. Discover the impact on investors and market reactions.
Moderna Shares Surge on Bird Flu Vaccine Hopes
Moderna shares rise as investors anticipate success in its experimental bird flu vaccine. Explore the potential impact on the biotech market.